About Medibios Laboratories Limited
Data last updated:
Medibios Laboratories Limited was a public limited company based in Mumbai, Maharashtra, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 March 1995.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1995PLC086180. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹10 Cr and a paid-up capital of ₹7.1 Cr. It was formerly known as Medibios Laboratories Private Limited. It was led by directors including Tushar Anil Korday (Managing Director) and Rajendra Fattesinh Gole (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at Mumbai, Maharashtra.
As per the financials filed for FY 2023, the company reported a revenue of ₹100.12 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹10.38 Cr (net margin 10.4%) and EBITDA of ₹20.99 Cr (EBITDA margin 21%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 11% over five years.
The company had about 138 employees on its provident fund (EPFO) records before it was dissolved.
The company was associated with 1 brand: Medibios. As per MCA filings, the company had satisfied charges of ₹39.29 Cr on record. Court records list 4 cases involving the company, including 3 filed by the company and 1 filed against it; 3 cases are pending.
The last known website on record is medibios.in.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address102 Shree Mangalam 1st Floor Kulupwadi, Borivali(E) India, Mumbai, Maharashtra, India
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Medibios Laboratories Limited
The main business activity of Medibios Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Medibios Laboratories Limited FY 2023 filings available
Medibios Laboratories Limited reported revenue of ₹100.12 Cr (down 2% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Medibios Laboratories Limited
Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 11%. EBITDA fell 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Medibios Laboratories Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹100.12 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹20.99 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹10.38 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Medibios Laboratories Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 21% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 10.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Medibios Laboratories are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Medibios Laboratories Limited
Medibios Laboratories Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sotac Pharmaceuticals Limited | ₹100.88 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Sanand, Gujarat, India |
| Lake Chemicals Private Limited | ₹100.59 Cr (FY 2025) | •••• | •••• | -5.0% | •••• | Bangalore, Karnataka, India |
| Credo Life Sciences Private Limited | ₹100.47 Cr (FY 2024) | •••• | •••• | 22.0% | •••• | Hyderabad, Telangana, India |
| Consern Pharma Limited | ₹100.37 Cr (FY 2025) | •••• | •••• | -2.0% | •••• | Ludhiana, Punjab, India |
| Addii Biotech Private Limited | ₹100.32 Cr (FY 2025) | •••• | •••• | 59.0% | •••• | Chandigarh, India |
| Medibios Laboratories Limited this company | ₹100.12 Cr (FY 2023) | •••• | •••• | -2.0% | •••• | Mumbai, Maharashtra, India |
| Angel Biogenics Private Limited | ₹99.49 Cr (FY 2025) | •••• | •••• | -22.0% | •••• | Rajkot, Gujarat, India |
| Synokem Lifesciences Private Limited | ₹99.46 Cr (FY 2025) | •••• | •••• | 108.0% | •••• | New Delhi, Delhi, India |
| Shri Nivas (Gujarat) Laboratories Pvt Ltd | ₹98.85 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Patna, Bihar, India |
| Claroid Pharmaceuticals Limited | ₹98.31 Cr (FY 2025) | •••• | •••• | 48.0% | •••• | Ahmedabad, Gujarat, India |
| Sirmour Remedies Private Limited | ₹98.1 Cr (FY 2025) | •••• | •••• | -18.0% | •••• | Paonta Sahib, Himachal Pradesh, India |
Peers are the five companies nearest above and the five nearest below Medibios Laboratories by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Medibios Laboratories Limited
Medibios Laboratories Limited is audited by ANIL THAKRAR AND CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ANIL THAKRAR AND CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Medibios Laboratories Limited
Medibios Laboratories has 5 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Yogesh Rajendra Gole | Director | 01 Nov 2011 | 14 Years 11 Months | As last reported |
| Tushar Anil Korday | Managing Director | 14 May 2010 | 16 Years 5 Months | As last reported |
| Sharad Kantilal Sheth Also directs: Mehta Chokshi & Shah LLP | Director | 20 Mar 2018 | 8 Years 6 Months | As last reported |
| Meena Sanjiv Kapadi Also directs: Prime Property Development Corporation Limited, Flamingo Pharmaceuticals Limited, B4u Broadband (India) Private Limited and 1 more | Director | 20 Mar 2018 | 8 Years 6 Months | As last reported |
| Rajendra Fattesinh Gole | Whole-Time Director | 20 Mar 2018 | 8 Years 6 Months | As last reported |
Ownership and Shareholding of Medibios Laboratories Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Medibios Laboratories Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Jun 2018 | Axis Bank Limited | ₹17 Cr | Satisfied |
| 09 Nov 2000 | State Bank of India | ₹2.34 Cr | Satisfied |
| 17 May 1999 | State Bank of India | ₹19.95 Cr | Satisfied |
Total charge records: 3 View all charges
Legal Cases of Medibios Laboratories Limited
Medibios Laboratories Limited has 4 court cases on record: 3 filed by Medibios Laboratories, 1 filed against it. 3 cases are pending and 1 is disposed. Status as checked between 30 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 0 | 2 |
| District courts | 1 | 1 | 1 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Calcutta High Court | Court case (CRR) | Filed by the company against an individual | Pending |
| High Court of Jammu and Kashmir and Ladakh | Criminal miscellaneous application | Filed by the company against an individual | Pending |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by an individual | Pending |
| High Court of Jammu and Kashmir and Ladakh | Criminal miscellaneous application | Filed by the company against an individual | Disposed |
Full case history
All 4 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Medibios Laboratories Limited
Medibios Laboratories operates one associated brand: Medibios. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing of pharmaceuticals including cardiovascular and anti-infective drugs in India. | medibios.in |
Employees and EPFO Compliance at Medibios Laboratories Limited
Medibios Laboratories Limited has a workforce of 138 employees as of Apr 05, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Medibios Laboratories Limited
Medibios Laboratories has one previous CIN (Corporate Identification Number): U24230MH1995PTC086180. The current CIN is U24230MH1995PLC086180, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230MH1995PLC086180 | Current |
| U24230MH1995PTC086180 | Previous |
Recent Activity on Medibios Laboratories Limited
Medibios Laboratories Limited has 14 board changes on record since 2004: 5 appointments and 9 cessations. The latest: Meena Sanjiv Kapadi ceased to be Additional Director on 29 Sep 2018.
13 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Medibios Laboratories Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Medibios Laboratories Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Medibios Laboratories Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Medibios Laboratories Limited
Medibios Laboratories has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Medibios Laboratories Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medibios Laboratories Limited
Medibios Laboratories has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Medibios Laboratories was a public limited company based in Mumbai, Maharashtra, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 08 March 1995 and is registered under CIN U24230MH1995PLC086180. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Medibios Laboratories was incorporated on 08 March 1995. It is registered with the Registrar of Companies, Mumbai.
Medibios Laboratories had 5 directors:
- Tushar Anil Korday - Managing Director
- Rajendra Fattesinh Gole - Whole-Time Director
- Yogesh Rajendra Gole - Director
- Sharad Kantilal Sheth - Director
- Meena Sanjiv Kapadi - Director
The CIN (Corporate Identification Number) of Medibios Laboratories is U24230MH1995PLC086180. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Medibios Laboratories is at 102 Shree Mangalam 1st Floor Kulupwadi, BorivaliE India, Mumbai, Maharashtra, India.
Medibios Laboratories can be reached through the website medibios.in. Its registered office is in Mumbai, Maharashtra, India.
Medibios Laboratories reported revenue of ₹100.12 Cr for FY 2023 (down 2% YoY).
Medibios Laboratories has an authorised share capital of ₹10 Cr and a paid-up capital of ₹7.1 Cr.
Medibios Laboratories reported a net profit of ₹10.38 Cr (net margin 10.4%) and EBITDA of ₹20.99 Cr (EBITDA margin 21%) for FY 2023, as per its filed financial statements.
No. Medibios Laboratories has 1 GST registration on record and it is cancelled or inactive.